Search

Author/Creator Dunham, Steven A.

1. A blinded, randomized, placebo‐controlled, dose determination trial of lokivetmab (ZTS‐00103289), a caninized, anti‐canine IL‐31 monoclonal antibody in client owned dogs with atopic dermatitis. Issue 6 (19th September 2016)

Authors:
Michels, Gina M.; Ramsey, Deborah S.; Walsh, Kelly F.; Martinon, Olivier M.; Mahabir, Sean P.; Hoevers, Jacquelien D.; Walters, Rodney R.; Dunham, Steven A.
Journal:
Veterinary dermatology
Issue:
Volume 27:Issue 6(2016:Dec.)
Page Start:
478
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Interleukin‐31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Issue 1 (19th January 2013)

Authors:
Gonzales, Andrea J.; Humphrey, William R.; Messamore, James E.; Fleck, Timothy J.; Fici, Gregory J.; Shelly, John A.; Teel, Janet F.; Bammert, Gary F.; Dunham, Steven A.; Fuller, Troy E.; McCall, Robert B.
Journal:
Veterinary dermatology
Issue:
Volume 24:Issue 1(2013:Feb.)
Page Start:
48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus. Issue 6 (8th April 2021)

Authors:
Fleck, Timothy J.; Norris, Lori R.; Mahabir, Sean; Walters, Rodney R.; Martinon, Olivier; Dunham, Steven A.; Gonzales, Andrea J.
Other Names:
Campbell‐Motsinger Karen L. guestEditor.; Roudebush Philip guestEditor.
Journal:
Veterinary dermatology
Issue:
Volume 32:Issue 6(2021)
Page Start:
681
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗